M&A TRANSACTION · 2026
University Compounding Pharmacy acquired by Fagron
$41.5M· Pharmacy
Target
University Compounding Pharmacy
Acquirer
Fagron
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$25.0M
EBITDA
-
Deal Value
$41.5M
What's your pharmacy worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $41.5M acquisition of University Compounding Pharmacy by Fagron sits in the pharmacy sub-vertical. Run a valuation for your own pharmacy business via our Pharmacy valuation hub. Fagron is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.
Source
Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the University Compounding Pharmacy acquisition.
More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Value a pharmacy· run the calculator
- Pharmacy median multiples· real-deal benchmarks
- Who buys pharmacy businesses?· active buyers
- Who acquired University Compounding Pharmacy?· buyer profile
- How to value a pharmacy· long-form guide